Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AERI

Aerie Pharmaceuticals

$45.94

0.34 (0.75%)

06:37
03/21/19
03/21
06:37
03/21/19
06:37
Hot Stocks
Aerie Pharmaceuticals initiates dosing for netarsudil ophthalmic solution study »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

AERI

Aerie Pharmaceuticals

$45.94

0.34 (0.75%)

04:50
03/21/19
03/21
04:50
03/21/19
04:50
Initiation
Aerie Pharmaceuticals initiated at Piper Jaffray »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Apr

Tuesday
AERI

Aerie Pharmaceuticals

$47.09

0.09 (0.19%)

07:38
03/19/19
03/19
07:38
03/19/19
07:38
Recommendations
Aerie Pharmaceuticals analyst commentary at Canaccord »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 08

    Apr

Monday
AERI

Aerie Pharmaceuticals

$47.09

0.09 (0.19%)

16:55
03/18/19
03/18
16:55
03/18/19
16:55
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

AERI

Aerie Pharmaceuticals

$47.00

-0.58 (-1.22%)

06:35
03/18/19
03/18
06:35
03/18/19
06:35
Hot Stocks
Aerie Pharmaceuticals initiates Phase 2 Clinical trial of AR-1105 »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

AERI

Aerie Pharmaceuticals

$47.00

-0.58 (-1.22%)

04:55
03/18/19
03/18
04:55
03/18/19
04:55
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

Over a week ago
AERI

Aerie Pharmaceuticals

$49.04

1.08 (2.25%)

13:20
03/14/19
03/14
13:20
03/14/19
13:20
Conference/Events
Aerie Pharmaceuticals management to meet with JMP Securities »

Group Dinner Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 18

    Mar

  • 19

    Mar

  • 08

    Apr

AERI

Aerie Pharmaceuticals

$45.78

-0.81 (-1.74%)

07:19
03/13/19
03/13
07:19
03/13/19
07:19
Recommendations
Aerie Pharmaceuticals analyst commentary at JMP Securities »

JMP Securities sees fast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 18

    Mar

  • 19

    Mar

AERI

Aerie Pharmaceuticals

$45.78

-0.81 (-1.74%)

18:32
03/12/19
03/12
18:32
03/12/19
18:32
Hot Stocks
Aerie Pharmaceuticals sees FY19 net cash burn $130M-$140M »

Net cash burn guidance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 14

    Mar

  • 18

    Mar

  • 19

    Mar

AERI

Aerie Pharmaceuticals

$45.78

-0.81 (-1.74%)

18:23
03/12/19
03/12
18:23
03/12/19
18:23
Hot Stocks
FDA approves Aerie Pharmaceuticals' Rocklatan in glaucoma or ocular hypertension »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

  • 14

    Mar

  • 18

    Mar

  • 19

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.